BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.

BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that …

Mar 10, 2026 · About BioNTech Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other …

Mar 10, 2026 · BioNTech, which developed and sold the COVID-19 shot with Pfizer (PFE.N), said it plans to contribute certain rights and mRNA technologies to the new company on an arm's-length …

Apr 8, 2026 · BioNTech’s fair value estimate has been trimmed from $139.51 to $131.39, a modest cut of about 6% that reflects the latest model inputs. This shift comes as analysts reassess the story …

Mar 10, 2026 · The husband-and-wife founders of German vaccine company BioNTech announced on Tuesday they would step down to pursue new innovations at a brand new firm.

2 days ago · Latest Biontech SE (BNTX:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Get real-time BioNTech SE - ADR (BNTX) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

4 days ago · MAINZ, Germany, April 21, 2026 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on …

Mar 10, 2026 · Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and …